Showing 1 - 6 results of 6 for search 'Masafumi Ikeda', query time: 0.03s Refine Results
  1. 1
    Covered self‐expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectable pancreatic cancer

    Covered self‐expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectable pancreatic cancer by Taro Shibuki, Ko Fukushi, Kanae Inoue, Tomonao Taira, Tomoyuki Satake, Kazuo Watanabe, Mitsuhito Sasaki, Hiroshi Imaoka, Shuichi Mitsunaga, Masafumi Ikeda

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Side‐by‐side versus stent‐in‐stent technique for stent deployment during systemic chemotherapy in biliary tract cancer patients with malignant hilar biliary obstruction

    Side‐by‐side versus stent‐in‐stent technique for stent deployment during systemic chemotherapy in biliary tract cancer patients with malignant hilar biliary obstruction by Shunsuke Imamura, Kazuo Watanabe, Kanae Inoue, Tomonao Taira, Taro Shibuki, Tomoyuki Satake, Shota Yamaguchi, Mitsuhito Sasaki, Hiroshi Imaoka, Shuichi Mitsunaga, Masafumi Ikeda

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer

    Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer by Makoto Ueno, Masafumi Ikeda, Do-Youn Oh, Masatoshi Kudo, Christoph Helwig, Changhoon Yoo, Hye Jin Choi, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Isabelle Dussault

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers

    Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers by Yasutoshi Kuboki, Masafumi Ikeda, Shigehisa Kitano, Takafumi Koyama, Noboru Yamamoto, Yuki Yamaguchi, Yuki Nakagawa, Takaaki Ishida, Hidenori Mizugaki, Takatsugu Narikiyo, Ryoko Takubo, Chika Ogami, Mayuko Sekiya

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination wit... by Yoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, Yoshitaka Inaba, Tatsuya Yamashita, Hideki Iwamoto, Makoto Ueno, Sadahisa Ogasawara, Teiji Kuzuya, Takahiro Kodama, Yozo Sato, Toshifumi Tada, Kaoru Tsuchiya, Hideyuki Nishiofuku, Koichiro Yamakado, Miyuki Sone, Masafumi Ikeda, Tetsuo Takehara, Tetsutaro Hamano, Masatoshi Kudo

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer

    Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer by Shuichi Mitsunaga, Masafumi Ikeda, Makoto Ueno, Satoshi Kobayashi, Masahiro Tsuda, Ikuya Miki, Takamichi Kuwahara, Kazuo Hara, Yukiko Takayama, Yutaro Matsunaga, Keiji Hanada, Akinori Shimizu, Hitoshi Yoshida, Tomohiro Nomoto, Kenji Takahashi, Hidetaka Iwamoto, Hideaki Iwama, Etsuro Hatano, Kohei Nakata, Masafumi Nakamura, Hiroko Sudo, Satoko Takizawa, Atsushi Ochiai

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: